SVB Financial Group’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

SVB Financial Group’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,923	Closed	-$65K	–	22
2023 Q2	$65K	Sell	35,923 -20,978	-37%	-$38.4K	0.12%	20
2023 Q1	$75.1K	Sell	56,901 -20,979	-27%	-$34.3K	0.14%	22
2022 Q4	$132K	Buy	+77,880	New	+$98.7K	0.36%	21

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

SVB Financial Group's PRDS Position: Q3 2023 in Review

SVB Financial Group sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 35,923 shares — an estimated $65K sold.

SVB Financial Group first reported a position in PRDS in Q4 2022 and held it in 3 quarters. The position peaked at $132K in Q4 2022. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

SVB Financial Group reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
SVB Financial Group sold 35,923 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $65K.
SVB Financial Group first reported a position in Pardes Biosciences, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
SVB Financial Group's Pardes Biosciences, Inc. Common Stock position peaked at $132K in Q4 2022.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on SVB Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.